Comparison of LigAmp and an ASPCR assay for detection and quantification of K103N-containing HIV variants

AIDS Research and Human Retroviruses

Volumn 24, Issue 4, 2008, Pages 595-605

  Church, Jessica D ^a   Towler, William I ^a   Hoover, Donald R ^b   Hudelson, Sarah E ^a   Kumwenda, Newton ^a   Taha, Taha E ^a   Eshleman, James R ^a   Eshleman, Susan H ^a,c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; NEVIRAPINE; OLIGONUCLEOTIDE; VIRUS DNA;

ALLELE; ARTICLE; CODON; CONTROLLED STUDY; DNA POLYMORPHISM; DNA TEMPLATE; FEMALE; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; INTERMETHOD COMPARISON; LIGATION AMPLIFICATION ASSAY; MAJOR CLINICAL STUDY; NUCLEOTIDE BINDING SITE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE DRUG DOSE; VIRUS DETECTION; VIRUS MUTATION; VIRUS STRAIN;

ANTI-HIV AGENTS; BASE SEQUENCE; DRUG RESISTANCE, VIRAL; FEMALE; GENES, POL; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; NEVIRAPINE; POINT MUTATION; POL GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; VARIATION (GENETICS);

EID: 42449083333     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2007.0224     Document Type: Article

References (23)

1. Guay LA, Musoke P, Fleming T, et al.: Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999;354:795-802.
2. Jackson JB, Musoke P, Fleming T, et al.: Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18 months follow-up of the HIVNET 012 randomised trial. Lancet 2003;362:859-868.
3. Eshleman SH, Mracna M, Guay LA, et al.: Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012). AIDS 2001;15:1951-1957.
4. Palmer S, Boltz V, Martinson N, et al.: Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission. Proc Natl Acad Sci USA 2006;103:7094-7099.
5. Martinson NA, Morris L, Gray G, et al.: Selection and persistence of viral resistance in HIV-infected children after exposure to single-dose nevirapine. J Acquir Immune Defic Syndr 2007;44:148-153.
6. Jourdain G, Ngo-Giang-Huong N, Le Coeur S, et al.: Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy. N Engl J Med 2004;351:229-240.
7. Lockman S, Shapiro RL, Smeaton LM, et al.: Response to antiretroviral therapy after a single, peripartum dose of nevirapine. N Engl J Med 2007;356:135-147.
8. Church JD, Jones D, Flys T, et al.: Sensitivity of the ViroSeq HIV-1 genotyping system for detection of the K103N resistance mutation in HIV-1 subtypes A, C, and D. J Mol Diagn 2006;8:430-432.
9. Palmer S, Kearney M, Maldarelli F, et al.: Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis. J Clin Microbiol 2005;43:406-413.
10. Shi C, Eshleman SH, Jones D, et al.: LigAmp for sensitive detection of single-nucleotide differences. Nat Methods 2004;1:141-147.
11. Flys T, Nissley DV, Claasen CW, et al.: Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012. J Infect Dis 2005;192:24-29.
12. Johnson JA, Li JF, Morris L, et al.: Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated. J Infect Dis 2005;192:16-23.
13. Halvas EK, Aldrovandi GM, Balfe P, et al.: Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency. J Clin Microbiol 2006;44:2612-2614.
14. Palmer S, Boltz V, Maldarelli F, et al.: Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy. AIDS 2006;20:701-710.
15. Cai F, Chen H, Hicks CB, Bartlett JA, Zhu J, and Gao F: Detection of minor drug-resistant populations by parallel allele-specific sequencing. Nat Methods 2007;4:123-125.
16. Hoffmann C, Minkah N, Leipzig J, et al.: DNA bar coding and pyrosequencing to identify rare HIV drug resistance mutations. Nucleic Acids Res 2007;35(13):e91.
17. Lalonde MS, Troyer RM, Syed AR, et al.: A sensitive oligonucleotide ligation assay for low-level detection of nevirapine resistance mutations in HIV-1 quasispecies. J Clin Microbiol 2007;45:2604-2615.
18. Paredes R, Marconi VC, Campbell TB, and Kuritzkes DR: Systematic evaluation of allele-specific real-time PCR for the detection of minor HIV-1 variants with pol and env resistance mutations. J Virol Methods 2007;146(1-2):136-146.
19. Flys TS, Chen S, Jones DC, et al.: Quantitative analysis of HIV-1 variants with the K103N resistance mutation after single-dose nevirapine in women with HIV-1 subtypes A, C, and D. J Acquir Immune Defic Syndr 2006;42:610-613.
20. Taha TE, Kumwenda NI, Hoover DR, et al.: Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: A randomized controlled trial. JAMA 2004;292:202-209.
21. Eshleman SH, Hoover DR, Chen S, et al.: Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP. J Infect Dis 2005;192:30-36.
22. Eshleman SH, Jones D, Flys T, Petrauskene O, and Jackson JB: Analysis of HIV-1 variants by cloning DNA generated with the ViroSeq HIV-1 Genotyping System. Biotechniques 2003;35:614-618, 620, 622.
23. Murphy KM, Berg KD, and Eshleman JR: Sequencing of genomic DNA by combined amplification and cycle sequencing reaction. Clin Chem 2005;51:35-39.